APA

Rex D. K., Bhandari R., Desta T., DeMicco M. P., Schaeffer C., Etzkorn K., Barish C. F., Pruitt R., Cash B. D., Quirk D., Tiongco F., Sullivan S. & Bernstein D. (20181214). A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. : Gastrointestinal endoscopy.

Chicago

Rex Douglas K, Bhandari Raj, Desta Taddese, DeMicco Michael P, Schaeffer Cynthia, Etzkorn Kyle, Barish Charles F, Pruitt Ronald, Cash Brooks D, Quirk Daniel, Tiongco Felix, Sullivan Shelby and Bernstein David. 20181214. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. : Gastrointestinal endoscopy.

Harvard

Rex D. K., Bhandari R., Desta T., DeMicco M. P., Schaeffer C., Etzkorn K., Barish C. F., Pruitt R., Cash B. D., Quirk D., Tiongco F., Sullivan S. and Bernstein D. (20181214). A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. : Gastrointestinal endoscopy.

MLA

Rex Douglas K, Bhandari Raj, Desta Taddese, DeMicco Michael P, Schaeffer Cynthia, Etzkorn Kyle, Barish Charles F, Pruitt Ronald, Cash Brooks D, Quirk Daniel, Tiongco Felix, Sullivan Shelby and Bernstein David. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. : Gastrointestinal endoscopy. 20181214.